Overall Health
DSIP vs. Melatonin: Comparing Peptide and Supplement Sleep Aids

DSIP and melatonin get compared as competing sleep aids. They are not really comparable: one has decades of human trials and is available in any pharmacy, the other has a thin and largely dated evidence base and requires a prescription. The comparison is still worth making, because they address genuinely different problems.
Different Mechanisms Entirely
Melatonin — a Timing Signal
Melatonin is a hormone produced by the pineal gland in response to darkness. It is a circadian timing signal, not a sedative. It tells the body when biological night is, rather than inducing sleep directly.
This is the source of most misuse. Taken for its timing effect at the right moment, melatonin is genuinely effective. Taken as a sedative at bedtime, it underperforms — and that is how the majority of people use it.
DSIP — Poorly Characterized
Delta sleep-inducing peptide is a nonapeptide first isolated in the 1970s from the cerebral venous blood of rabbits in induced sleep. It was named for an association with delta-wave (slow-wave) sleep.
Its mechanism remains poorly characterized. Proposed actions include effects on GABAergic signaling, modulation of corticotropin and somatotropin release, and interaction with opioid systems. It does not have a single well-established receptor target. Our DSIP peptide profile covers what is known.
Honest framing: DSIP research is mostly from the 1970s–1990s, mostly small, and has not been substantially advanced by modern controlled trials.
Side by Side
| Melatonin | DSIP | |
|---|---|---|
| Type | Endogenous hormone | Nonapeptide |
| Mechanism | Circadian timing via MT1/MT2 receptors | Poorly characterized |
| Best evidence | Circadian rhythm disorders, jet lag, delayed sleep phase | Limited; mostly small older studies |
| Availability | Over the counter (US) | Prescription, compounded |
| Typical effective dose | 0.5–1 mg, well below common OTC doses | No established protocol |
| Timing | Critical — hours before target sleep for phase shifting | Not established |
| Evidence quality | Substantial | Thin |
| Tolerance | Not well documented | Unknown |
The Melatonin Dosing Problem
Most commercial melatonin is dosed at 3, 5, or 10 mg. The physiological nocturnal rise is a fraction of that, and controlled research generally finds 0.5 to 1 mg as effective as higher doses for circadian effects — sometimes more effective, since excessive doses can produce daytime grogginess and, by keeping levels elevated into the morning, blunt the very rhythm being targeted.
Timing matters more than dose. For advancing sleep phase in someone who cannot fall asleep until late, a small dose several hours before the target bedtime is the evidence-supported approach — not a large dose at bedtime.
Licensed Healthcare Practitioners
6,500+ physician-grade product SKUs, bulk-tier pricing, and direct shipping to your practice. NPI verified, no consumer access.
A further complication in the US: melatonin is regulated as a dietary supplement, and analyses have found substantial discrepancies between labeled and actual content, in both directions.
Which Problem Are You Solving
Melatonin fits: jet lag, shift work, delayed sleep phase syndrome, non-24-hour rhythm disorders in blind individuals, and circadian disruption generally. This is where the evidence is.
Melatonin does not fit well: classic sleep-maintenance insomnia — waking at 3 a.m. and being unable to return to sleep — where the problem is not circadian timing.
DSIP is used for: sleep quality and slow-wave sleep specifically, sometimes in patients who have not responded to conventional approaches. The evidence supporting this use is limited.
What Outperforms Both
Cognitive behavioural therapy for insomnia (CBT-I) is first-line treatment for chronic insomnia in essentially every clinical guideline, with better long-term outcomes than pharmacological approaches. It is under-used mainly because it requires more effort than a bottle.
Also worth ruling out before pursuing either compound: sleep apnea, restless legs, caffeine timing, alcohol (which reliably fragments the second half of the night), and untreated anxiety or depression. Our overview of the best peptides for sleep and recovery covers the broader peptide category.
Frequently Asked Questions
Is DSIP better than melatonin for sleep?
They address different problems. Melatonin has strong evidence for circadian timing issues. DSIP is studied for sleep quality and slow-wave sleep but has a thin, largely dated evidence base. Melatonin has the stronger evidence overall.
How much melatonin should I take?
Research generally finds 0.5 to 1 mg as effective as higher doses for circadian effects, well below the 3 to 10 mg in most commercial products. Timing matters more than dose. Discuss with a provider, particularly for ongoing use.
Why doesn't melatonin help me sleep?
Melatonin is a circadian timing signal rather than a sedative. If your problem is sleep maintenance — waking in the night — rather than circadian timing, melatonin addresses the wrong mechanism.
Is DSIP available over the counter?
No. DSIP is a compounded prescription preparation, unlike melatonin, which is sold as a dietary supplement in the United States.
Can DSIP and melatonin be combined?
Some protocols do, on the rationale that they act through different mechanisms. There is no trial evidence supporting the combination, and it should be discussed with a prescriber.
What works better than either?
Cognitive behavioural therapy for insomnia is first-line for chronic insomnia in clinical guidelines, with better long-term outcomes than pharmacological approaches. Screening for sleep apnea is also worthwhile before pursuing any sleep compound.
More from the blog
Continue reading

Peptide Therapy for Athletes: Recovery, Performance and Compliance
What peptides are studied for athletic recovery, and the anti-doping reality — most are prohibited by WADA at all times, including BPC-157 and TB-500.
Oct 7, 2026

BPC-157 for Post-Surgical Recovery: What to Expect
What the BPC-157 research does and does not support for surgical recovery, the timing and angiogenesis questions, and what to raise with your surgeon.
Oct 5, 2026

Thymosin Beta-4 vs BPC-157: Which Peptide for Recovery?
How BPC-157 and TB-500 differ mechanistically, which tissues each is studied in, and why they are frequently used together rather than chosen between.
Oct 2, 2026
For Licensed Providers
